Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRVA · against 350 other Healthcare companies of similar size
Ranked #220 of 351 · scores higher than 36% of peers
Bars: peers in each 10-point band of the valuation score36 peers with a valuation score of 40–49, including PRVA · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PRVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 343 reported | 1.0% | 2.3% | 40% | 30% | |
| EBITDA yieldHigher is better · 348 reported | 2.4% | 4.7% | 35% | 50% | |
| Free cash flow yieldHigher is better · 179 reported | 4.8% | 0.2% | 74% | 20% | |
| Book yieldHigher is better · 343 reported | 28.9% | 32.1% | 45% | Context only |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score